Famotidine Powder, For Suspension
Product Images NDC 42571-433

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 42571-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Famotidine-50ml.jpg (Famotidine 50ml)

Famotidine for Oral Suspension, USP 40 mg/5 mL powder for suspension label. Contains 50 mL when reconstituted. Manufactured by Micro Labs Limited, India, and for Micro Labs USA, Inc. Instructions include storage conditions, inactive ingredients, dosage form, reconstitution directions, and usual adult dosage reference to prescribing information. The label warnings state oral use only and to shake well before each use.*

FDA Label Image

Famotidine-str.jpg (Famotidine Str)

Chemical structure of famotidine, showing the molecular arrangement including a thiazole ring and attached functional groups consistent with the famotidine molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.